Spleen-derived mesenchymal stem cells promote progression of pancreatic cancer
碩士 === 國立成功大學 === 臨床醫學研究所 === 105 === In 2016, pancreatic cancer has the third highest incidence rate of cancer related fatality in the Unites States, with the 5 year overall survival rate of about 8%, exhibiting the lack of treatment strategies. To increase the chance of cure for locally advanced p...
Main Authors: | YuWu, 吳予 |
---|---|
Other Authors: | Yan-Shen Shan |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/md8v8k |
Similar Items
-
The usage of spleen-derived mesenchymal stem cell for the treatment of pancreatitis in mice
by: Chen-FangHuang, et al.
Published: (2013) -
Pancreatic ductal-derived mesenchymal stem cells : their distribution, characterization and cytotoxic effect on pancreatic cancer cells
by: Roshan Moniri, Mani
Published: (2012) -
Pancreatic ductal-derived mesenchymal stem cells : their distribution, characterization and cytotoxic effect on pancreatic cancer cells
by: Roshan Moniri, Mani
Published: (2012) -
Pancreatic ductal-derived mesenchymal stem cells : their distribution, characterization and cytotoxic effect on pancreatic cancer cells
by: Roshan Moniri, Mani
Published: (2012) -
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5
by: Nishikawa, Gen
Published: (2019)